Well thinking that it was`nt the Algo`s and a well orchestrated plan, is just being naive.They`ve been working this stock since Adage came in,in 2015. Even before that when it was a penny stock. Like I said,most spec Bio`s are plagued by the Algo`s driven by the short cabal. Many times it`s the Tutes that own shares,like in our case. Once we`re approved and have revenue,most of the abuse will subside,until then we`re a see saw at their beck an call,minus big news,unexpected. Fortunately,I think we`re about to get that big news,and maybe even back to back. The Golden boys that just entered our fold know what they`re doing,and I`m sure they`ll be in the black soon enough. This week could be it,but when it comes the shorts that are left will cover and thrust the share price upwards,especially if it`s real good,like a Merck deal.